Clinical trial
A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2…
NCT00144144 · Advanced-J, Other · Unknown status
Key facts
| NCT number | NCT00144144 |
|---|---|
| Title | A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes |
| Official title | A Randomized, Controlled Study on Calcium Channel Blocker Versus Angiotensin II Antagonists in the Hypertensive Patients With Type 2 Diabetes Mellitus Under the Inadequately Controlled Blood Pressure With Angiotension II Antagonists |
| Lead sponsor | Advanced-J, Other |
| Collaborators | Japan Heart Foundation |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Angiotensin II receptor antagonists, Calcium channel blocker |
| Enrollment | 300 |
| Start date | Sep 1, 2004 |
| Completion | Sep 1, 2008 |
| First posted | Sep 5, 2005 |
| Last update posted | Jul 14, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: